The global filtration market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.2 billion in 2026 and USD 15.0 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. In last five years, over 50 biologics been approved by the FDA and close to 10,000 biologics are being evaluated across different stages of development. Notably, biopharmaceutical filtration systems are used to separate and purify these biological products, including proteins, antibodies and vaccines...

The global pharmacy market, valued at USD 2.5 trillion in 2025, is projected to reach USD 2.6 trillion in 2026 and USD 4.1 trillion by 2035, with a 5% CAGR during the forecast period 2026 to 2035. According to the US health department, around 133 million Americans live with at least one chronic disease. In order to address this, the pharmacy industry, comprising both independent stores and chains are offering a wide range of prescription drugs, over-the-counter drugs, medical devices and other...

The global plant based protein expression market, valued at USD 2.42 billion in 2025, is projected to reach USD 2.98 billion in 2026 and USD 5.81 billion by 2035, with a 7.68% CAGR during the forecast period 2026 to 2035. It is worth highlighting that our research indicates that the existing mammalian cell capacities are likely to fulfill only 50% of the inflated demand (due to COVID-19) for biologics. In this context, plant based expression systems have emerged as a promising alternative fo...

The global non-viral drug delivery systems market, valued at USD 8.6 billion in 2025, is projected to reach USD 11.3 billion in 2026 and USD 20.4 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In September 2024, NanoSyrinx raised USD 13 million in a seed funding round, in order to advance its intracellular nanosyringe technology that is aimed to target biologics to the sites that are difficult to target within the cell. The market report presents an in-depth analysis...

The global KRAS market size, valued at USD 476 million in 2024, is projected to reach USD 557 million in 2025 and USD 3,894 million by 2035, representing a CAGR of 21% during the forecast period. One of these oncogenic mutations is KRAS, which was identified to be associated with nearly 30% of cancer in humans. One of the key objectives of KRAS market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided...

The cytotoxic drugs and HPAPI manufacturing market, valued at USD 13.98 billion in 2025, is projected to grow to USD 15.59 billion in 2026 and USD 46.41 billion by 2035, representing a CAGR of 12.89% during the forecast period 2026 to 2035. Around 40% of approved drugs in the market are classified as highly potent. Of these, 60% of the approved HPAPI-based drugs are used for cancer treatment, owing to their ability to exhibit highly effective therapeutic responses with minimal dosage.

The global lyophilization services market, valued at USD 3.0 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 4.7 billion by 2035, with a 4.3% CAGR during the forecast period 2026 to 2035. Antibodies market segment holds the largest share of the market and are poised to capture 52% of the overall revenue share by 2035.

The global orthopedic devices market size, valued at USD 60.56 billion in 2024, is projected to reach USD 63.51 billion in 2025 and USD 92.61 billion by 2035, representing a CAGR of 3.8% during the forecast period. Driven by the increasing adoption, several industrial players have shown active participation in this field to develop advanced orthopedic devices to meet unmet requirements of patients. However, the primary focus of industrial players will remain on technological innovations, wearabl...

The global orthopedic implants market, valued at USD 48.11 billion in 2024, is expected to grow to USD 50.83 billion in 2025 and USD 79.31 billion by 2035, representing a CAGR of 4.5% during the forecast period. According to the report of American College of Rheumatology, every year nearly around 790,000 total knee replacements and 544,000 hip replacements are done the U.S. Examples of key players engaged in this orthopedic implants industry include Arthrex, Acumed, Aesculap Implant Systems, Alp...

The global orphan drug market size is expected to grow from USD 236.27 billion in 2025 to reach USD 667.48 billion by 2035, representing a CAGR of 10.94% over the forecast period. With rising risk of rare diseases and some rare oncological disorders, the demand for orphan drugs has significantly increased to treat patients. A recent report published by National Center for Advancing Translational Sciences highlighted that nearly 10,000 rare diseases affect the US population. Moreover, according t...

The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. According to an Oxford Academic report, nearly 2.6% of the population is affected by atopic dermatitis worldwide where children are more affected compared to adults,. This number exhibits a high prevalence of skin conditions similar to eczema that raise the atopic dermatitis market demand. Atopic dermatitis also kno...

The bioreactors market size is estimated to grow from $16.7 billion currently to $51.7 billion by 2035, representing a CAGR of 11.1% during the forecast period, till 2035. The global expansion of biopharmaceutical products has led to significant growth in the bioprocessing supplies market. Over the past two decades, this market has consistently grown at an annual rate of between 12 and 14%. With companies either establishing their own biopharmaceutical manufacturing facilities or outsourcing pro...

The global chronic kidney disease market size is valued at USD 38.91 billion in 2024 and is expected to reach USD 67.36 billion by 2035, representing a CAGR of 5.12% during the forecast period. Chronic kidney disease (CKD) refers to the long-term condition in which a patient gradually loses its kidney function. In most cases, patients suffering from chronic kidney disease remain undiagnosed until the kidney function declined to 75% as its symptoms are rarely observed (which include swollen ankle...

The global SARM1 inhibitor market size is estimated to be worth USD 5 million in 2033 and is expected to reach USD 727 million by 2040, growing at a CAGR of 102% during the forecast period. According to a United Nations report, nearly 1 billion people around the world suffer from various neurological conditions. Further a WHO report states that the U.S. alone spends more than USD 655 billion every year on neurological disorders. Consequently, the rising incidence of neurological disorders has ex...

The global DNA damage response market is estimated to grow from USD 390 million in 2026 to reach USD 1,071 million by 2030 representing a higher CAGR of 28.7% during the forecast period. Although majority of the drug candidates for molecular targets (other than PARP) are in the preclinical / initial clinical stages, drug developers are optimistic regarding the therapeutic potential of this emerging class of drugs. Gradually, a substantial body of evidence, validating the efficacy of drugging the...

The blockbuster drugs market was worth around $75 billion in 2020. Less than half a century ago, the pharmaceutical market was dominated by small molecule drugs. Notably, the first biologic, humanized insulin, was approved in 1982; over time, this class of target specific therapeutics have revolutionized the healthcare industry. Presently, biologics represent the fastest growing product segment within the global pharmaceutical industry. In fact, as of September 2020, over 430 biological interven...

The global continuous manufacturing systems market is estimated to grow from USD 378 million in 2025 to reach USD 483 million in 2026 and USD 1,750 million by 2035, representing a higher CAGR of 15.4% during the forecast period. Given the ever-increasing demand for pharmacological interventions, and the introduction of new and sophisticated therapeutic modalities, drug substance manufacturers are gradually opting for more advanced manufacturing solutions, such as continuous flow reactor. When co...